travoprost 0.004% eye drops

DRUG2 trials

Sponsors

Allergan, Alcon Research

Conditions

GlaucomaOcular HypertensionOpen-angle Glaucoma

Phase 4

Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%

CompletedNCT00440011

AllerganGlaucoma, Ocular Hypertension

Start: 2006-08-31End: 2007-10-31Updated: 2019-04-25

Adherence Assessment With Travalert Dosing Aid

CompletedNCT00508469

Alcon ResearchOcular Hypertension, Open-angle Glaucoma

Start: 2007-10-31End: 2010-01-31Updated: 2012-07-12